{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:26:33Z","timestamp":1779935193899,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00284-020-02123-y","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T11:28:10Z","timestamp":1596108490000},"page":"3158-3167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains"],"prefix":"10.1007","volume":"77","author":[{"given":"Min Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo In","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-7521","authenticated-orcid":false,"given":"Myeong Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"2123_CR1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520\u2013532","journal-title":"N Engl J Med"},{"key":"2123_CR2","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM199808203390806","volume":"10","author":"KS Kaye","year":"2004","unstructured":"Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10:1125. https:\/\/doi.org\/10.1056\/NEJM199808203390806","journal-title":"Emerg Infect Dis"},{"key":"2123_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jac\/40.1.135","volume":"40","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135\u2013136. https:\/\/doi.org\/10.1093\/jac\/40.1.135","journal-title":"J Antimicrob Chemother"},{"key":"2123_CR4","unstructured":"Wikler MA (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. CLSI (NCCLS) 26:M7\u2013A7"},{"key":"2123_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","volume":"1","author":"K Hiramatsu","year":"2001","unstructured":"Hiramatsu K (2001) Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 1:147\u2013155. https:\/\/doi.org\/10.1016\/S1473-3099(01)00091-3","journal-title":"Lancet Infect Dis"},{"key":"2123_CR6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/JCM.02135-08","volume":"47","author":"AC Musta","year":"2009","unstructured":"Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, Khatib R (2009) Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol 47:1640\u20131644. https:\/\/doi.org\/10.1128\/JCM.02135-08","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2123_CR7","doi-asserted-by":"publisher","first-page":"e0136082","DOI":"10.1371\/journal.pone.0136082","volume":"10","author":"S Zhang","year":"2015","unstructured":"Zhang S, Sun X, Chang W, Dai Y, Ma X (2015) Systematic review and meta-analysis of the epidemiology of vancomycin-intermediate and heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. PLoS One 10(8):e0136082. https:\/\/doi.org\/10.1371\/journal.pone.0136082","journal-title":"PLoS One"},{"key":"2123_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00042-09","volume":"23","author":"BP Howden","year":"2010","unstructured":"Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23:99\u2013139. https:\/\/doi.org\/10.1128\/CMR.00042-09","journal-title":"Clin Microbiol Rev"},{"key":"2123_CR9","doi-asserted-by":"publisher","DOI":"10.4172\/2327-5073.1000214","author":"Y Devi","year":"2015","unstructured":"Devi Y, Punithavathy P, Thomas S, Veeraraghavan B (2015) Challenges in the laboratory diagnosis and clinical management of heteroresistant vancomycin Staphylococcus aureus (hVISA). Clin Microbiol Open Access. https:\/\/doi.org\/10.4172\/2327-5073.1000214","journal-title":"Clin Microbiol Open Access"},{"key":"2123_CR10","unstructured":"bioM\u00e9rieux SA (2012) Etest application guide. https:\/\/www.biomerieux-usa.com\/sites\/subsidiary_us\/files\/supplementary_inserts_-_16273_-_b_-_en_-_eag_-_etest_application_guide-3.pdf"},{"key":"2123_CR11","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1128\/AAC.00275-07","volume":"51","author":"C Milheiri\u00e7o","year":"2007","unstructured":"Milheiri\u00e7o C, Oliveira DC, de Lencastre H (2007) Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 51:3374\u20133377. https:\/\/doi.org\/10.1128\/AAC.00275-07","journal-title":"Antimicrob Agents Chemother"},{"key":"2123_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/JCM.01128-10","volume":"49","author":"SW Satola","year":"2011","unstructured":"Satola SW, Farley MM, Anderson KF, Patel JB (2011) Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol 49:177\u2013183. https:\/\/doi.org\/10.1128\/JCM.01128-10","journal-title":"J Clin Microbiol"},{"key":"2123_CR13","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1128\/JCM.00265-08","volume":"46","author":"A Yusof","year":"2008","unstructured":"Yusof A, Engelhardt A, Karlsson \u00c5, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR (2008) Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. J Clin Microbiol 46:3042\u20133047. https:\/\/doi.org\/10.1128\/JCM.00265-08","journal-title":"J Clin Microbiol"},{"key":"2123_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jac\/dkn520","volume":"63","author":"SN Leonard","year":"2009","unstructured":"Leonard SN, Rossi KL, Newton KL, Rybak MJ (2009) Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides. J Antimicrob Chemother 63:489\u2013492. https:\/\/doi.org\/10.1093\/jac\/dkn520","journal-title":"J Antimicrob Chemother"},{"key":"2123_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jiac.2014.06.012","volume":"20","author":"H Hanaki","year":"2014","unstructured":"Hanaki H, Cui L, Ikeda-Dantsuji Y, Nakae T, Honda J, Yanagihara K, Takesue Y, Matsumoto T, Sunakawa K, Kaku M (2014) Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011. J Infect Chemother 20:527\u2013534. https:\/\/doi.org\/10.1016\/j.jiac.2014.06.012","journal-title":"J Infect Chemother"},{"key":"2123_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.diagmicrobio.2011.06.010","volume":"71","author":"H Chen","year":"2011","unstructured":"Chen H, Liu Y, Sun W, Chen M, Wang H (2011) The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC. Diagn Microbiol Infect Dis 71:301\u2013303. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.06.010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2123_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10096-009-0868-4","volume":"29","author":"C-M Ho","year":"2010","unstructured":"Ho C-M, Hsueh P-R, Liu C-Y, Lee S-Y, Chiueh T-S, Shyr J-M, Tsao S-M, Chuang Y-C, Yan J-J, Wang L-S (2010) Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan\u2014SMART program, 2003. Eur J Clin Microbiol Infect Dis 29:383\u2013389. https:\/\/doi.org\/10.1007\/s10096-009-0868-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2123_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jmii.2012.05.004","volume":"45","author":"S-Y Lin","year":"2012","unstructured":"Lin S-Y, Chen T-C, Chen F-J, Chen Y-H, Lin Y-I, Siu LK, Lu P-L (2012) Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center. J Microbiol Immunol Infect 45:435\u2013441. https:\/\/doi.org\/10.1016\/j.jmii.2012.05.004","journal-title":"J Microbiol Immunol Infect"},{"key":"2123_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1215-2","volume":"15","author":"H-C Hu","year":"2015","unstructured":"Hu H-C, Kao K-C, Chiu L-C, Chang C-H, Hung C-Y, Li L-F, Liu T-P, Lin L-C, Chen N-H, Huang C-C (2015) Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units. BMC Infect Dis 15:1. https:\/\/doi.org\/10.1186\/s12879-015-1215-2","journal-title":"BMC Infect Dis"},{"key":"2123_CR20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/jcm.40.4.1376-1380.2002","volume":"40","author":"M-N Kim","year":"2002","unstructured":"Kim M-N, Hwang SH, Pyo Y-J, Mun H-M, Pai CH (2002) Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol 40:1376\u20131380. https:\/\/doi.org\/10.1128\/jcm.40.4.1376-1380.2002","journal-title":"J Clin Microbiol"},{"key":"2123_CR21","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1128\/AAC.48.12.4926-4928.2004","volume":"48","author":"J-H Song","year":"2004","unstructured":"Song J-H, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, Kiem S, Kim Y-S, Oh WS, Peck KR (2004) Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 48:4926\u20134928. https:\/\/doi.org\/10.1128\/AAC.48.12.4926-4928.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2123_CR22","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/jac\/dks131","volume":"67","author":"K-H Park","year":"2012","unstructured":"Park K-H, Kim ES, Kim HS, Park S-J, Bang KM, Park HJ, Park S-Y, Moon SM, Chong YP, Kim S-H (2012) Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus. J Antimicrob Chemother 67:1843\u20131849. https:\/\/doi.org\/10.1093\/jac\/dks131","journal-title":"J Antimicrob Chemother"},{"key":"2123_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3343\/alm.2016.36.3.235","volume":"36","author":"YR Koh","year":"2016","unstructured":"Koh YR, Kim KH, Chang CL, Yi J (2016) Prevalence and clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus isolated from hospitalized patients. Ann Lab Med 36:235\u2013243. https:\/\/doi.org\/10.3343\/alm.2016.36.3.235","journal-title":"Ann Lab Med"},{"key":"2123_CR24","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1128\/AAC.01365-08","volume":"53","author":"K Horne","year":"2009","unstructured":"Horne K, Howden BP, Grabsch EA, Graham M, Ward P, Xie S, Mayall BC, Johnson PD, Grayson ML (2009) Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother 53:3447\u20133452. https:\/\/doi.org\/10.1128\/AAC.01365-08","journal-title":"Antimicrob Agents Chemother"},{"key":"2123_CR25","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1128\/JCM.00582-08","volume":"46","author":"MJ Rybak","year":"2008","unstructured":"Rybak MJ, Leonard SN, Rossi KL, Cheung CM, Sadar HS, Jones RN (2008) Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). J Clin Microbiol 46:2950\u20132954. https:\/\/doi.org\/10.1128\/JCM.00582-08","journal-title":"J Clin Microbiol"},{"key":"2123_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jac\/dki413","volume":"57","author":"F Garnier","year":"2006","unstructured":"Garnier F, Chainier D, Walsh T, Karlsson A, Bolmstr\u00f6m A, Grelaud C, Mounier M, Denis F, Ploy M-C (2006) A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J Antimicrob Chemother 57:146\u2013149. https:\/\/doi.org\/10.1093\/jac\/dki413","journal-title":"J Antimicrob Chemother"},{"key":"2123_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/jac\/dki272","volume":"56","author":"B Sancak","year":"2005","unstructured":"Sancak B, Ercis S, Menemenlio\u011flu D, \u00c7olako\u011flu \u015e, Has\u00e7elik G (2005) Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 56:519\u2013523. https:\/\/doi.org\/10.1093\/jac\/dki272","journal-title":"J Antimicrob Chemother"},{"key":"2123_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1086\/381093","volume":"38","author":"PG Charles","year":"2004","unstructured":"Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML (2004) Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 38:448\u2013451. https:\/\/doi.org\/10.1086\/381093","journal-title":"Clin Infect Dis"},{"key":"2123_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1086\/422458","volume":"39","author":"S Cosgrove","year":"2004","unstructured":"Cosgrove S, Carroll K, Perl T (2004) Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis 39:539\u2013545. https:\/\/doi.org\/10.1086\/422458","journal-title":"Clin Infect Dis"},{"key":"2123_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1086\/346207","volume":"36","author":"SK Fridkin","year":"2003","unstructured":"Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC, Group V-ISaES (2003) Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001. Clin Infect Dis 36:429\u2013439. https:\/\/doi.org\/10.1086\/346207","journal-title":"Clin Infect Dis"},{"key":"2123_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1086\/381202","volume":"38","author":"BP Howden","year":"2004","unstructured":"Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K (2004) Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38:521\u2013528. https:\/\/doi.org\/10.1086\/381202","journal-title":"Clin Infect Dis"},{"key":"2123_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1474651408100353","volume":"9","author":"LM Hakeem","year":"2009","unstructured":"Hakeem LM, Urolagin M, Bhattacharyya DN, Campbell IW, Griffiths G (2009) Haemorrhagic bullous Streptococcus pneumoniae cellulitis in type 2 diabetes mellitus. Br J Diabetes Vasc Dis 9:75\u201379. https:\/\/doi.org\/10.1177\/1474651408100353","journal-title":"Br J Diabetes Vasc Dis"},{"key":"2123_CR33","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","volume":"341","author":"N Joshi","year":"1999","unstructured":"Joshi N, Caputo GM, Weitekamp MR, Karchmer A (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906\u20131912. https:\/\/doi.org\/10.1056\/NEJM199912163412507","journal-title":"N Engl J Med"},{"key":"2123_CR34","doi-asserted-by":"publisher","first-page":"e23633","DOI":"10.1371\/journal.pone.0023633","volume":"6","author":"F Hanses","year":"2011","unstructured":"Hanses F, Park S, Rich J, Lee JC (2011) Reduced neutrophil apoptosis in diabetic mice during staphylococcal infection leads to prolonged Tnf\u03b1 production and reduced neutrophil clearance. PLoS One 6:e23633. https:\/\/doi.org\/10.1371\/journal.pone.0023633","journal-title":"PLoS One"},{"key":"2123_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1086\/596629","volume":"199","author":"Y Maor","year":"2009","unstructured":"Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199:619\u2013624. https:\/\/doi.org\/10.1086\/596629","journal-title":"J Infect Dis"},{"key":"2123_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-0711-6-13","volume":"6","author":"HM Neoh","year":"2007","unstructured":"Neoh HM, Hori S, Komatsu M, Oguri T, Takeuchi F, Cui L, Hiramatsu K (2007) Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob 6:1. https:\/\/doi.org\/10.1186\/1476-0711-6-13","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2123_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF01963643","volume":"9","author":"F Brunet","year":"1990","unstructured":"Brunet F, Vedel G, Dreyfus F, Vaxelaire J, Giraud T, Schremmer B, Monsallier J (1990) Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur J Clin Microbiol Infect Dis 9:145\u2013147. https:\/\/doi.org\/10.1007\/BF01963643","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2123_CR38","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1128\/aac.47.10.3040-3045.2003","volume":"47","author":"C Liu","year":"2003","unstructured":"Liu C, Chambers HF (2003) Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47:3040\u20133045. https:\/\/doi.org\/10.1128\/aac.47.10.3040-3045.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2123_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000239002","volume":"38","author":"J Huebner","year":"1992","unstructured":"Huebner J, Kropec A, Engels I, Daschner F (1992) In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid. Chemotherapy 38:206\u2013210. https:\/\/doi.org\/10.1159\/000239002","journal-title":"Chemotherapy"},{"key":"2123_CR40","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1128\/JCM.02144-10","volume":"49","author":"Y Watanabe","year":"2011","unstructured":"Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K (2011) Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J Clin Microbiol 49:2680\u20132684. https:\/\/doi.org\/10.1128\/JCM.02144-10","journal-title":"J Clin Microbiol"},{"key":"2123_CR41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7883\/yoken.64.28","volume":"64","author":"A Japoni","year":"2011","unstructured":"Japoni A, Jamalidoust M, Farshad S, Ziyaeyan M, Alborzi A, Japoni S, Rafaatpour N (2011) Characterization of SCCmec types and antibacterial susceptibility patterns of methicillin-resistant Staphylococcus aureus in Southern Iran. Jpn J Infect Dis 64:28\u201333","journal-title":"Jpn J Infect Dis"},{"key":"2123_CR42","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1128\/aac.44.6.1549-1555.2000","volume":"44","author":"Y Katayama","year":"2000","unstructured":"Katayama Y, Ito T, Hiramatsu K (2000) A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 44:1549\u20131555. https:\/\/doi.org\/10.1128\/aac.44.6.1549-1555.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2123_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.meegid.2018.03.013","volume":"61","author":"S Baig","year":"2018","unstructured":"Baig S, Johannesen TB, Overballe-Petersen S, Larsen J, Larsen AR, Stegger M (2018) Novel SCCmec type XIII (9A) identified in an ST152 methicillin-resistant Staphylococcus aureus. Infect Genet Evol 61:74\u201376. https:\/\/doi.org\/10.1016\/j.meegid.2018.03.013","journal-title":"Infect Genet Evol"},{"key":"2123_CR44","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00579-09","volume":"53","author":"Elements IWGotCoSCC","year":"2009","unstructured":"Elements IWGotCoSCC (2009) Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 53:4961\u20134967. https:\/\/doi.org\/10.1128\/AAC.00579-09","journal-title":"Antimicrob Agents Chemother"},{"key":"2123_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jmii.2015.07.003","volume":"49","author":"S-H Huang","year":"2015","unstructured":"Huang S-H, Chen Y-C, Chuang Y-C, Chiu S-K, Fung C-P, Lu P-L, Wang L-S, Wu T-L, Wang J-T (2015) Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: a multicenter surveillance study, 2012\u20132013. J Microbiol Immunol Infect 49:701\u2013707. https:\/\/doi.org\/10.1016\/j.jmii.2015.07.003","journal-title":"J Microbiol Immunol Infect"},{"key":"2123_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/mdr.2014.0190","volume":"21","author":"S Di Gregorio","year":"2015","unstructured":"Di Gregorio S, Perazzi B, Ordonez AM, De Gregorio S, Foccoli M, Lasala MB, Garc\u00eda S, Vay C, Famiglietti A, Mollerach M (2015) Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospital. Microb Drug Resist 21:25\u201334. https:\/\/doi.org\/10.1089\/mdr.2014.0190","journal-title":"Microb Drug Resist"},{"key":"2123_CR47","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/JCM.37.9.2858-2862.1999","volume":"37","author":"F O\u2019brien","year":"1999","unstructured":"O\u2019brien F, Pearman J, Gracey M, Riley T, Grubb W (1999) Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 37:2858\u20132862","journal-title":"J Clin Microbiol"},{"key":"2123_CR48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1086\/379022","volume":"37","author":"L Saiman","year":"2003","unstructured":"Saiman L, Keefe MO, Graham PL, Wu F, Salim BS, Kreiswirth B, LaSala A, Schlievert PM, Della Latta P (2003) Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37:1313\u20131319. https:\/\/doi.org\/10.1086\/379022","journal-title":"Clin Infect Dis"},{"key":"2123_CR49","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3201\/eid1106.040885","volume":"11","author":"S Bratu","year":"2005","unstructured":"Bratu S, Eramo A, Kopec R, Coughlin E, Ghitan M, Yost R, Chapnick EK, Landman D, Quale J (2005) Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 11:808\u2013813. https:\/\/doi.org\/10.3201\/eid1106.040885","journal-title":"Emerg Infect Dis"},{"key":"2123_CR50","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.43.7.3435-3437.2005","volume":"43","author":"PA Trindade","year":"2005","unstructured":"Trindade PA, Pacheco RL, Costa SF, Rossi F, Barone AA, Mamizuka EM, Levin AS (2005) Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:3435\u20133437. https:\/\/doi.org\/10.1128\/JCM.43.7.3435-3437.2005","journal-title":"J Clin Microbiol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-02123-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-020-02123-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-02123-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T04:49:13Z","timestamp":1667623753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-020-02123-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2123"],"URL":"https:\/\/doi.org\/10.1007\/s00284-020-02123-y","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed according to the principles of the Declaration of Helsinki and was approved by the Gangdong KyungHee University Hospital Ethics Committee (IRB No. KHNMC 2020-03-047). The committee waived the need for ethics approval and the need to obtain consent for the collection, analysis and publication of the retrospectively obtained and anonymized data for this non-interventional study with the samples of clinical isolates.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}